Leah Kleinman

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. ncbi The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument
    Leah Kleinman
    Center for Health Outcomes Research, United BioSource Corporation, Seattle, Washington 98121, USA
    Clin Gastroenterol Hepatol 4:588-96. 2006
  2. ncbi Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function
    Leah Kleinman
    United BioSource Corporation, Seattle, WA 98101, United States
    Schizophr Res 107:275-85. 2009
  3. ncbi Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model
    Leah Kleinman
    United BioSource Corporation, Seattle, WA 98101, USA
    Behav Sleep Med 11:23-36. 2013
  4. ncbi Review of patient-reported outcome measures in chronic hepatitis C
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 10:92. 2012
  5. ncbi Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children
    Leah Kleinman
    United BioSource Corporation, Center for Health Outcomes Research, Seattle, WA 98121, USA
    Curr Gastroenterol Rep 8:230-6. 2006
  6. ncbi Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD 20814, USA
    J Pediatr Gastroenterol Nutr 52:514-22. 2011
  7. ncbi Psychometric performance of an assessment scale for strain in nursing care: the M-NCAS
    Leah Kleinman
    MEDTAP International, Inc, 2601 4th Ave, Seattle, WA 98121, USA
    Health Qual Life Outcomes 2:62. 2004
  8. ncbi Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:135-49. 2006
  9. ncbi Patient-based utilities for bipolar disorder-related health states
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 87:203-10. 2005
  10. ncbi Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:151-62. 2006

Detail Information

Publications23

  1. ncbi The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument
    Leah Kleinman
    Center for Health Outcomes Research, United BioSource Corporation, Seattle, Washington 98121, USA
    Clin Gastroenterol Hepatol 4:588-96. 2006
    ..We revised the Infant Gastroesophageal Reflux Questionnaire (I-GERQ) on the basis of information from parents of infants with GERD and physicians and subjected it to a psychometric evaluation...
  2. ncbi Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function
    Leah Kleinman
    United BioSource Corporation, Seattle, WA 98101, United States
    Schizophr Res 107:275-85. 2009
    ..The SOFI has good evidence supporting reliability and construct validity, and may be a useful measure of functional outcomes in schizophrenia...
  3. ncbi Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model
    Leah Kleinman
    United BioSource Corporation, Seattle, WA 98101, USA
    Behav Sleep Med 11:23-36. 2013
    ..Each conceptual framework consists of hypothesized domains and items in each domain based on patient language taken from the focus group. These item pools may ultimately serve as a basis to develop new questionnaires to assess insomnia...
  4. ncbi Review of patient-reported outcome measures in chronic hepatitis C
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 10:92. 2012
    ..The goal of this work was to provide recommendations for incorporation of PRO measurement of concepts that are relevant to the CHC experience into CHC clinical trial design...
  5. ncbi Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children
    Leah Kleinman
    United BioSource Corporation, Center for Health Outcomes Research, Seattle, WA 98121, USA
    Curr Gastroenterol Rep 8:230-6. 2006
    ..Measures of pediatric GERD symptoms include the GERQ, GERQ-R, and GSQ. These measures have advantages and disadvantages with regard to feasibility, reliability, and validity. Questionnaires are lacking for children older than 4 years...
  6. ncbi Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD 20814, USA
    J Pediatr Gastroenterol Nutr 52:514-22. 2011
    ..These include the PGSQ-Cp (for children ages 2 to 8 years, parent/caregiver report) and the PGSQ-A (for adolescents ages 9-17 years). The objective of the present study was to develop and evaluate PGSQ measurement properties...
  7. ncbi Psychometric performance of an assessment scale for strain in nursing care: the M-NCAS
    Leah Kleinman
    MEDTAP International, Inc, 2601 4th Ave, Seattle, WA 98121, USA
    Health Qual Life Outcomes 2:62. 2004
    ..Nurses rate items in terms of extent to which the behavior or characteristic is present ("attitude" domain), and extent to which it is a burden ("strain" domain)...
  8. ncbi Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:135-49. 2006
    ....
  9. ncbi Patient-based utilities for bipolar disorder-related health states
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 87:203-10. 2005
    ..This study estimated health state utilities for hypothetical bipolar-related health states and patient's current health from bipolar I patients...
  10. ncbi Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:151-62. 2006
    ....
  11. ncbi Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel
    Gale Harding
    United BioSource Corporation, Bethesda, MD 20814, USA
    Curr Med Res Opin 25:1563-71. 2009
    ..A secondary objective was to determine the lowest threshold for a clinically meaningful difference in terms of both between-group differences and maximum acceptable placebo effect...
  12. ncbi Costs of bipolar disorder
    Leah Kleinman
    MEDTAP International Inc, Bethesda, Maryland, USA
    Pharmacoeconomics 21:601-22. 2003
    ..Intangible costs such as family burden and impaired health-related quality of life are common, although it has proved difficult to attach monetary values to these costs...
  13. ncbi The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy
    Leah Kleinman
    Outcomes Research, United BioSource Corporation, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 21:1255-66. 2012
    ..To develop a patient-reported outcome instrument for measuring anemia symptoms and their impact in patients with chemotherapy-induced anemia (CIA)...
  14. ncbi Using GI-specific patient outcome measures in renal transplant patients: validation of the GSRS and GIQLI
    Leah Kleinman
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Qual Life Res 15:1223-32. 2006
    ..Little effort has been made to quantify the impact of these side-effects on patients' health-related quality of life and symptom severity...
  15. ncbi The effect of risperidone on nursing burden associated with caring for patients with dementia
    Lori Frank
    MEDTAP International, Bethesda, Maryland 20814, USA
    J Am Geriatr Soc 52:1449-55. 2004
    ..To compare risperidone treatment with placebo for the burden to nursing staff of older nursing-home residents with dementia...
  16. ncbi Willingness to pay for complete symptom relief of gastroesophageal reflux disease
    Leah Kleinman
    MEDTAP International, Bethesda, MD, USA
    Arch Intern Med 162:1361-6. 2002
    ..This study is an economic analysis of patients' willingness to pay for a prescription medication that offers complete relief of GERD symptoms...
  17. ncbi Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis
    Parthiv J Mahadevia
    MEDTAP International Inc, Bethesda, Maryland, USA
    Ann Allergy Asthma Immunol 93:345-50. 2004
    ..Application of patient preferences when selecting INSs could improve adherence...
  18. ncbi Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases
    Lori Frank
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, Maryland 20814, USA
    Clin Ther 24:675-89; discussion 674. 2002
    ..Despite the rapidly growing body of literature on health-related quality of life (HRQoL). placing the results in a context that is meaningful to clinicians and patients is often overlooked...
  19. ncbi The validation of a caregiver assessment of dementia: the Dementia Severity Scale
    Philip D Harvey
    Mt Sinai School of Medicine, New York, New York 10029, USA
    Alzheimer Dis Assoc Disord 19:186-94. 2005
    ..The Dementia Severity Scale is designed to measure deficits in activities of daily living (ADL), behavioral disturbances, and the caregiver's perception of the patient's current cognitive abilities...
  20. ncbi Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medication
    Jesse Green
    F Hoffmann La Roche Inc, Nutley, New Jersey 07110 1199, USA
    HIV Clin Trials 3:387-95. 2002
    ..It measures ease of use and impact of treatment on daily life. This study presents the results of a psychometric evaluation of the SIS...
  21. ncbi Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial
    Rainer Oberbauer
    Allgemeines Krankenhaus, Wien, Austria
    Transplantation 75:1277-85. 2003
    ..5-point change). CONCLUSIONS: SRL-based therapy with early elimination of CsA results in fewer appearance-related problems, less fatigue, and better vitality compared with continuous treatment with SRL, CsA, and ST...
  22. ncbi Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitis
    Parthiv Mahadevia
    Global Health Economics, Amgen, Inc, 555 13th St NW, Suite 600 West, Washington, DC 20004, USA
    J Manag Care Pharm 12:143-51. 2006
    ..As part of the same study, we also sought to determine if these same patients are willing to pay for products not containing certain sensory attributes...
  23. ncbi Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    David Bernstein
    North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Hepatology 35:704-8. 2002
    ..In conclusion, sustained virologic response is associated with improvements in quality of life in patients with or without advanced liver disease. This parameter may be an important consideration in maximizing treatment adherence...